Healthcare -
Biotechnology - NASDAQ - US
$ 74.92
1.56 %
$ 14.4 B
Market Cap
832.44
P/E
INCY - COST OF REVENUE
Cost of Revenue INCY - Incyte Corporation
255 M
LAST VALUE
29.96%
2 YEAR CAGR
22.06%
5 YEAR CAGR
82.27%
10 YEAR CAGR